Alcalamente
Alcala de Henares, Madrid, Spain
Private psychiatry center in Alcala de Henares authorized to administer esketamine (Spravato) for treatment-resistant depression under medical supervision, with a standard protocol of two weekly sessions during the initial month. Serves the Madrid region and Guadalajara.
Treatments offered
Spravato (esketamine)
The one psychedelic-adjacent medicine the FDA has approved for treatment-resistant depression, and for depression with acute suicidal thinking. Given at a certified center and often covered by insurance after prior authorization.
Pricing
This provider does not publish prices. Contact them directly for a quote, and ask what a full course costs rather than a single session.
Insurance and reimbursement
Spravato is billed through insurance at certified centers, usually after prior authorization. Confirm network status with this provider.
- Spravato is FDA-approved, so most commercial plans plus Medicare and Medicaid cover it after prior authorization.
- The clinic submits the prior authorization; approval usually requires documented failure of two or more oral antidepressants.
- You pay your plan's normal specialist copay per visit, and the manufacturer's copay program can reduce that further for commercial plans.
Who can apply
- A specialist psychiatric assessment.
- Esketamine typically requires documented treatment-resistant depression.
Legal basis: Legal, prescription only, European Union
Ketamine and esketamine are prescription medicines across the EU. Specialist clinics, mainly in Germany, the Netherlands, Spain, and Portugal, offer treatment for depression under medical supervision.
More on legality hereSources
Where this listing's information came from. Always confirm details with the provider before booking.